The effect of ticagrelor on the adenosine system.
Phase of Trial: Phase IV
Latest Information Update: 09 Jan 2014
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes; Coronary artery disease; Embolism and thrombosis; Peripheral arterial disorders
- Focus Pharmacodynamics
- Acronyms Ticagrelor-adenosine
- 09 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Dec 2013 Planned End Date changed from 3 Oct 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.